Mechanism of Enhancing Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma

Medicine, Gastroenterology, Oncology, Life Sciences, Cell Biology, Biochemistry, Immunology,
pancreatic ductal adenocarcinoma   chemotherapy efficacy   paricalcitol   hydroxychloroquine   autophagy   tumor microenvironment   immune activation  

Research Report on Enhancing Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma with Paricalcitol and Hydroxychloroquine Background Pancreatic Ductal Adenocarcinoma (PDAC) has an extremely low survival rate, with a 5-year survival rate of less than 15%. The primary reasons are early tumor metastasis and high resistance to chemotherapy and ra...

Development and Validation of a Deep Learning Radiomics Model with Clinical-Radiological Characteristics for the Identification of Occult Peritoneal Metastases in Patients with Pancreatic Ductal Adenocarcinoma

Information Science, Computer Science, Artificial Intelligence, Medicine, Medical Laboratory Science, Medical Imaging, Oncology,
deep learning   radiomics   occult peritoneal metastases   pancreatic ductal adenocarcinoma   computed tomography  

Development and Validation of a Deep Learning Radiomics Model Combined with Clinical Radiological Features for Predicting Occult Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma Background Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal malignancy with a 5-year survival rate of approximately 11%. The poor progn...